Investing.com-- U.S. shares of pharmaceutical giant Merck & Co rose to a record high in aftermarket trade on Tuesday after the U.S. Food and Drug Administration approved its drug for the treatment of a rare lung disease.\n\nMerck  https://enavate.microsoftcrmportals.com/forums/general-discussion/3d38794e-1fec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/4af4f8b1-21ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/4cf4f8b1-21ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/4ef4f8b1-21ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/ea9d10be-21ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/0ce901b8-21ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/14e901b8-21ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/0ee901b8-21ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/10e901b8-21ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/12e901b8-21ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/16e901b8-21ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/8a3b57ff-27ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/8c3b57ff-27ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/8e3b57ff-27ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/2d9c6e05-28ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/299c6e05-28ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/2b9c6e05-28ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/6fca960b-28ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/319c6e05-28ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/2f9c6e05-28ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/339c6e05-28ec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/5b15fd72-2aec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/5715fd72-2aec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/5915fd72-2aec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/48942e79-2aec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/46942e79-2aec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/6015fd72-2aec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/5d15fd72-2aec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/4a942e79-2aec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/6515fd72-2aec-ee11-a73c-0022484d9402 https://enavate.microsoftcrmportals.com/forums/general-discussion/6315fd72-2aec-ee11-a73c-0022484d9402 https://thecontingent.microsoftcrmportals.com/forums/general-discussion/5bc07ab7-2fec-ee11-a73c-000d3a5cf430 https://thecontingent.microsoftcrmportals.com/forums/general-discussion/60c07ab7-2fec-ee11-a73c-000d3a5cf430 https://thecontingent.microsoftcrmportals.com/forums/general-discussion/62c07ab7-2fec-ee11-a73c-000d3a5cf430 https://thecontingent.microsoftcrmportals.com/forums/general-discussion/0aad8fbd-2fec-ee11-a73c-000d3a5cf430 https://thecontingent.microsoftcrmportals.com/forums/general-discussion/12ad8fbd-2fec-ee11-a73c-000d3a5cf430 https://thecontingent.microsoftcrmportals.com/forums/general-discussion/6cc07ab7-2fec-ee11-a73c-000d3a5cf430 https://thecontingent.microsoftcrmportals.com/forums/general-discussion/64c07ab7-2fec-ee11-a73c-000d3a5cf430 https://thecontingent.microsoftcrmportals.com/forums/general-discussion/67c07ab7-2fec-ee11-a73c-00